CytomX Therapeutics CTMX Intangible Amortization
Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by CytomX Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's intangible amortization?
- CytomX Therapeutics (CTMX) reported intangible amortization of $37K in Q1 2026.
- How has CytomX Therapeutics's intangible amortization changed year-over-year?
- CytomX Therapeutics's intangible amortization increased by 2.8% year-over-year, from $36K to $37K.
- What is the long-term trend for CytomX Therapeutics's intangible amortization?
- Over 4 years (2021 to 2025), CytomX Therapeutics's intangible amortization has grown at a 0.0% compound annual growth rate (CAGR), from $146K to $146K.
- What does intangible amortization mean?
- Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.